PPARGC1A and age-related macular degeneration: EMT is also featured in fundus retinopathy, especially retinal fibrotic diseases, such as subretinal fibrosis, in age-related macular degeneration (AMD) [94], wherein PGC-1α inhibits mitochondrial biogenesis and metabolic functioning in human retinal pigment epithelial cells [37,95].